Journal Information
Vol. 46. Issue 3.
Pages 148-150 (March 2010)
Share
Share
Download PDF
More article options
Vol. 46. Issue 3.
Pages 148-150 (March 2010)
Case Report
Full text access
Lymphangioleiomyomatosis in a Post-Menopausal Women
Linfangioleiomiomatosis en mujer posmenopáusica
Visits
6711
Cristina Soler-Ferrer
Corresponding author
, Albert Gómez-Lozano, Carles Clemente-Andrés, Eulàlia De Cendra-Morera, Montserrat Custal-Teixidor, Joan Colomer-Pairés
Departamento de Medicina Interna. Hospital de Santa Caterina, IAS, Salt, Girona, Spain
This item has received
Article information
Abstract

Lymphangioleiomyomatosis is a rare disease characterised by pulmonary cysts with abnormal proliferation in the lymphatic system. It occurs almost exclusively in women of fertile age due to a hormonal influence, for this reason it is extremely rare in post-menopausal patients. In these cases it is usually associated with hormone replacement therapies. It is known that this disease is strongly associated with other conditions, such as tuberous sclerosis and renal angiomyolipomas.

The case of a post-menopausal patient suffering from lymphangioleiomyomatosis, with no history of hormone therapy is presented. Renal angiomyolipomas and clinical signs indicative of a probable tuberous sclerosis were also detected.

Keywords:
Lymphangioleiomyomatosis
Renal angiomyolipoma
Tuberous sclerosis
Post-menopause
Resumen

La linfangioleiomiomatosis es una enfermedad rara caracterizada por quistes pulmonares con proliferación anómala del sistema linfático. Se presenta casi en exclusiva en mujeres en edad fértil debido a una influencia hormonal, por lo que resulta sumamente infrecuente en pacientes posmenopáusicas. En estos casos suele tener relación con tratamientos hormonales sustitutivos. Es conocido que esta enfermedad tiene un alto grado de asociación con otras afecciones, como la esclerosis tuberosa y los angiomiolipomas renales.

Presentamos el caso de una paciente posmenopáusica afecta de linfangioleiomiomatosis, sin ningún antecedente de tratamientos hormonales, en la que se detectaron, además, angiomiolipomas renales y criterios clínicos indicativos de esclerosis tuberosa en grado de probable.

Palabras clave:
Linfangioleiomiomatosis
Angiomiolipoma renal
Esclerosis tuberosa
Posmenopausia
Full text is only aviable in PDF
References
[1.]
E.J. Sullivan.
Lymphangiomyomatosis: a review.
Chest, 114 (1998), pp. 1689-1703
[2.]
E. Hancok, S. Tomkins, J. Sampson, J. Osborne.
Lymphangioleiomyomatosis and tuberous sclerosis.
Respir Med, 96 (2000), pp. 7-13
[3.]
S.R. Johnson.
Lymphangioleiomyomatosis.
Eur Respir J, 27 (2006), pp. 1056-1065
[4.]
L.A. Kerr, M.L. Blute, J.H. Ryu, S.J. Swensen, R.S. Malek.
Renal angiomyolipoma in association with pulmonary lymphangioleiomyoma: forme fruste of tuberous sclerosis?.
Urology, 41 (1993), pp. 440-444
[5.]
J. Charlo-Charles, G.W. Jones.
Renal angiomyolipoma associated with tuberous sclerosis: review of the literature.
Urology, 3 (1974), pp. 465-469
[6.]
W.J. Monteforte, P.W. Kohnen.
Angiomyolipomas in a case of lymphangiomyomatosis syndrome: realtionships to tuberous sclerosis.
Cancer, 34 (1974), pp. 317-321
[7.]
E.S. Roach, M.R. Gómez, H. Northrup.
Tuberous sclerosis complex consenus conference: revised clinical diagnostic criteria.
J Child Neurol, 13 (1998), pp. 624-628
[8.]
S.R. Johnson, C.I. Whale, R.B. Hubbard, S.A. Lewis, A.E. Tattersfield.
Survival and disease progression in UK patients with lymphangioleiomyomatosis.
Thorax, 59 (2004), pp. 800-803
[9.]
K. Matsui, K. Takeda, Z.X. Yu, W. Stetler-Stevenson, W.D. Travis, J. Moss, et al.
Down regulation of estrogen (ER) and progesterone (PR) receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy: an immunohistochemical study.
Am J Respir Crit Care Med, 161 (2000), pp. 1002-1009
[10.]
K.S. McCarty, J.A. Mossler, R. McLelland, H.O. Sieker.
Pulmonary lymphangioleiomyomatosis responsive to progesterone.
N Engl J Med, 303 (1985), pp. 1461-1465
[11.]
M. Barberis, G.P. Monti, G. Ziglio, E. De Juli, S. Veronese, S. Harari.
Oestrogen and progesterone receptors detection in pulmonary lymphangioleiomyomatosis.
Am J Respir Crit Care Med, 153 (1996), pp. 271
[12.]
S.R. Johnson, A.E. Tattersfield.
Clinical experience of lymphangiomyomatosis in the UK.
Thorax, 55 (2000), pp. 1052-1057
[13.]
J. Campos Franco, E. Otero Antón, A. Palacios Bartolomé, E. Varo Pérez.
Lymphangioleiomyomatosis in a postmenopausal woman under estrogen therapy.
Med Clin (Barc), 124 (2005), pp. 319
[14.]
D.E. Maziak, D.C. Kesten, D.C. Rappaport, J. Maurer.
Extrathoracic angiomyoliomas in limphangioleiomyomatosis.
Eus Respir J, 9 (1996), pp. 402-405
[15.]
J. Ponce, A. Barbagelata, E. Romero, P. Marcos, J. Sánchez, L. Álvarez, et al.
Angiolipomatosis renal y linfangioleiomiomatosis, su relación con la enfermedad de Bourneville.
Actas Urol Esp, 30 (2006), pp. 386-393
[16.]
J. Bissler, F.X. McCormack, L.R. Young, J.M. Elwing, G. Chuck, J.M. Leonard, et al.
Sirolimus for angiomyolpoma in tuberous sclerosis complex or lymphangioleiomyomatosis.
N Engl J Med, 358 (2008), pp. 140-151
Copyright © 2010. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?